It will be interesting to determine whether non-neuroendocrine “inflammatory” tumor cells with restored ZFP36L1 emerge as a resistance mechanism to LSD1 inhibitors to evade SCLCs inherent neuroendocrine dependence. The gene discussed is ZFP36L1; the disease is neoplasm.